ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in ADC Therapeutics SA as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −3 vs. Q3 2023
- Shares held
- 34.0M
- −5.49M (−13.9%) vs. Q3 2023
- Total value
- $56.4M
- +$21.0M (+59.3%) vs. Q3 2023
- New holders
- 8
- 7 more added
- Sold out
- 11
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmile Group, LLC | 15,328,317 | $25.4M | 0.91% | +1,150,272+8.1% | Added |
| Prosight Management, LP | 6,471,800 | $10.7M | 4.31% | +1,069,759+19.8% | Added |
| Millennium Management LLC | 2,672,810 | $4.44M | 0.00% | +22,559+0.9% | Added |
| Citadel Advisors LLC | 1,853,412 | $3.08M | 0.00% | −1,044,709−36.0% | Reduced |
| Bank of America Corp | 1,525,741 | $2.53M | 0.00% | −8,190−0.5% | Reduced |
| Goldman Sachs Group Inc | 1,459,514 | $2.42M | 0.00% | +406,536+38.6% | Added |
| Affinity Asset Advisors, LLC | 1,013,540 | $1.68M | 0.34% | −86,460−7.9% | Reduced |
| Vantage Consulting Group Inc | 850,737 | $1.41M | 0.95% | 00.0% | Unchanged |
| Morgan Stanley | 781,937 | $1.30M | 0.00% | +117,910+17.8% | Added |
| Blue Owl Capital Holdings LP | 733,568 | $1.22M | 0.29% | 00.0% | Unchanged |
| GCM Grosvenor Holdings, LLC | 410,888 | $682.1K | 0.12% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 144,858 | $240.0K | 0.00% | −11,190−7.2% | Reduced |
| Jane Street Group, LLC | 101,260 | $168.1K | 0.00% | +101,260 | New |
| Indie Asset Partners, LLC | 92,700 | $153.9K | 0.14% | 00.0% | Unchanged |
| Miracle Mile Advisors, LLC | 84,496 | $140.3K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 80,086 | $132.0K | 0.00% | +80,086 | New |
| Hennion & Walsh Asset Management, Inc. | 65,936 | $109.5K | 0.01% | +8,069+13.9% | Added |
| Magnetar Financial LLC | 55,762 | $92.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 43,650 | $72.5K | 0.02% | −23,401−34.9% | Reduced |
| DLK Investment Management, LLC | 33,155 | $55.0K | 0.03% | +33,155 | New |
| Marshall Wace, LLP | 21,848 | $36.3K | 0.00% | −416,825−95.0% | Reduced |
| Susquehanna International Group, LLP | 20,689 | $34.3K | 0.00% | +20,689 | New |
| Saxony Capital Management, LLC | 20,623 | $34.2K | 0.05% | +20,623 | New |
| Commonwealth Equity Services, LLC | 19,852 | $33.0K | 0.00% | +19,852 | New |
| Moneta Group Investment Advisors LLC | 19,496 | $32.4K | 0.00% | 00.0% | Unchanged |
| Lynx Capital Group Ltd | 15,000 | $24.9K | 0.02% | +15,000 | New |
| Tower Research Capital LLC (TRC) | 14,641 | $24.3K | 0.00% | +10,521+255.4% | Added |
| Advisor Group Holdings, Inc. | 14,000 | $23.2K | 0.00% | −8,629−38.1% | Reduced |
| Evergreen Capital Management LLC | 11,000 | $18.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,030 | $7.00K | 0.00% | −4,055−50.2% | Reduced |
| Group One Trading, L.P. | 2,232 | $3.71K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,179 | $1.00K | 0.00% | −53−4.3% | Reduced |
| Focused Wealth Management, Inc | 300 | $498 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 250 | $415 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 207 | $344 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 100 | $166 | 0.00% | +100 | New |
| Federation des caisses Desjardins du Quebec | 20 | $33 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 6 | $10 | 0.00% | −1,309−99.5% | Reduced |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −3,294,534−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,647,030−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −1,068,468−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −529,890−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −257,162−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −121,897−100.0% | Sold out |
| ELCO Management Co., LLC | 0 | $0 | 0.00% | −21,532−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −19,752−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |